Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 77.00 | |
5 mg | In stock | $ 182.00 | |
10 mg | In stock | $ 288.00 | |
25 mg | In stock | $ 582.00 | |
50 mg | In stock | $ 833.00 | |
100 mg | In stock | $ 1,150.00 | |
500 mg | In stock | $ 2,290.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 258.00 |
Description | AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats. |
Targets&IC50 | CB1:9.91 nM (IC50), CB2:13000 nM (IC50) |
Molecular Weight | 557.21 |
Formula | C21H19Cl2IN4O2 |
CAS No. | 202463-68-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 12 mg/mL (21.54 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AM281 202463-68-1 GPCR/G Protein Cannabinoid Receptor inhibit Inhibitor neurotoxicity SH-SY5Y CB1 memory AM-281 AM 281 inhibitor